Skip to main content
. 2022 Jun 12;23(12):6564. doi: 10.3390/ijms23126564

Figure 6.

Figure 6

Some strategies applied for the development of hyaluronic acid-based bioinks. (A) Bioink of hyaluronic acid and alginate for the bioprinting of NIH 3T3 cells. (Reproduced with permission from [203]. Copyright MDPI, 2021); and (B) bioink based on thiol-modified hyaluronic acid and a growth factor (TGF-β1) for the bioprinting of MSCs for chondrogenic differentiation (Reproduced with permission from [205,206]. Copyright John Wiley & Sons, Inc. and MDPI, 2022).